Neurgain Technologies, Inc., was founded in 2013 by Martin Marsala, Professor of Anesthesiology, UC San Diego School of Medicine, and Michael Krupp, CEO—a proven leader with a track record in large pharma companies and leading several startups including Xfibra, Inc., to develop the technologies arising from Dr. Marsala’s. Dr. Marsala’s work has focused on the treatment of spinal cord trauma-includuced neuropathic pain a...
Neurgain Technologies, Inc., was founded in 2013 by Martin Marsala, Professor of Anesthesiology, UC San Diego School of Medicine, and Michael Krupp, CEO—a proven leader with a track record in large pharma companies and leading several startups including Xfibra, Inc., to develop the technologies arising from Dr. Marsala’s. Dr. Marsala’s work has focused on the treatment of spinal cord trauma-includuced neuropathic pain and has produced numerous scientific publications and several patents.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.